Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Want to see HK:2373 full AI Analyst Report?
Top Page
Beauty Farm Medical & Health Industry, Inc.
(2373)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$30.00
â–²(13.81% Upside)
Action:ReiteratedDate:11/30/25
Beauty Farm Medical & Health Industry, Inc. demonstrates strong financial performance with robust revenue growth and profitability. However, the technical analysis indicates a bearish trend, which weighs down the overall score. The valuation is fair, with a reasonable P/E ratio and a modest dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Revenue Growth
Sustained ~20% revenue growth across core aesthetic services and product sales indicates durable market demand and successful commercial execution. Over the medium term this supports scale benefits, incremental margin expansion opportunities, and provides a larger base for reinvestment into services, products and network expansion.
Negative Factors
Moderate Leverage / Low Equity Ratio
Moderate leverage combined with a relatively low equity ratio reduces the capital cushion against shocks and can constrain financial flexibility. In adverse conditions or when pursuing aggressive expansion, the firm may face higher refinancing costs or limited room for additional debt, affecting strategic optionality.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained ~20% revenue growth across core aesthetic services and product sales indicates durable market demand and successful commercial execution. Over the medium term this supports scale benefits, incremental margin expansion opportunities, and provides a larger base for reinvestment into services, products and network expansion.
Read all positive factors
Beauty Farm Medical & Health Industry, Inc. (2373) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$5.27B
Dividend Yield1.97%
Average Volume (3M)539.77K
Price to Earnings (P/E)18.1
Beta (1Y)0.43
Revenue Growth16.70%
EPS Growth38.98%
CountryHK
Employees5,609
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.75
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)4.08
Price to Sales (P/S)1.50
P/FCF Ratio5.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.31Price Target Upside18.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.75
Revenue Forecast (FY)HK$4.02B
Beauty Farm Medical & Health Industry, Inc. Business Overview & Revenue Model
Company Description
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, suc...
How the Company Makes Money
Beauty Farm Medical & Health Industry, Inc. generates revenue primarily through a diverse range of services and product sales. Key revenue streams include aesthetic treatment services, which encompass procedures like laser treatments, injectables,...
Beauty Farm Medical & Health Industry, Inc. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.89B | 2.57B | 2.15B | 1.64B | 1.78B | 1.50B |
| Gross Profit | 1.38B | 1.19B | 977.10M | 717.84M | 833.79M | 700.02M |
| EBITDA | 497.57M | 427.49M | 644.82M | 452.43M | 554.51M | 473.71M |
| Net Income | 268.72M | 228.46M | 215.66M | 103.11M | 193.47M | 150.96M |
Balance Sheet | ||||||
| Total Assets | 4.31B | 4.28B | 3.30B | 2.50B | 2.48B | 2.10B |
| Cash, Cash Equivalents and Short-Term Investments | 2.00B | 1.83B | 1.57B | 910.63M | 1.08B | 801.92M |
| Total Debt | 779.08M | 730.59M | 563.12M | 525.50M | 515.46M | 515.69M |
| Total Liabilities | 3.38B | 3.30B | 2.47B | 2.29B | 2.21B | 1.96B |
| Stockholders Equity | 881.02M | 944.64M | 801.90M | 188.75M | 257.36M | 140.87M |
Cash Flow | ||||||
| Free Cash Flow | 1.04B | 682.44M | 466.27M | 241.21M | 536.76M | 613.03M |
| Operating Cash Flow | 984.28M | 796.63M | 625.51M | 382.00M | 669.93M | 680.53M |
| Investing Cash Flow | -394.38M | -340.85M | -711.18M | 53.63M | -385.35M | -368.94M |
| Financing Cash Flow | -325.44M | -223.36M | 133.74M | -432.82M | -271.06M | -273.33M |
Beauty Farm Medical & Health Industry, Inc. Technical Analysis
Neutral
26.36
Price Trends
22.71
Negative
24.52
Negative
28.09
Negative
Market Momentum
-0.54
Negative
48.69
Neutral
68.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2373, the sentiment is Neutral. The current price of 26.36 is above the 20-day moving average (MA) of 20.15, above the 50-day MA of 22.71, and below the 200-day MA of 28.09, indicating a neutral trend. The MACD of -0.54 indicates Negative momentum. The RSI at 48.69 is Neutral, neither overbought nor oversold. The STOCH value of 68.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2373.
Beauty Farm Medical & Health Industry, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$7.02B | 7.50 | 15.36% | 2.61% | 7.60% | 17.41% | |
67 Neutral | HK$1.40B | 5.35 | 18.05% | 4.37% | -4.23% | 3.95% | |
66 Neutral | HK$5.27B | 18.12 | 33.08% | 1.97% | 16.70% | 38.98% | |
62 Neutral | HK$7.37B | 43.03 | 0.62% | ― | -9.81% | -72.54% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$79.10M | 2.02 | 1.67% | ― | -4.86% | ― | |
49 Neutral | HK$6.65B | -6.17 | -10.66% | 2.38% | -5.73% | -442.94% |
* Healthcare Sector Average
HK:2373
Beauty Farm Medical & Health Industry, Inc.
21.46
5.15
31.58%
HK:1526
Rici Healthcare Holdings Ltd.
0.88
-0.09
-9.28%
HK:1951
Jinxin Fertility Group Ltd.
2.38
-0.52
-17.93%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.14
0.02
17.36%
HK:2273
Gushengtang Holdings Limited
30.34
-0.84
-2.69%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
11.83
-2.41
-16.92%
Beauty Farm Medical & Health Industry, Inc. Corporate Events
Beauty Farm Issues Positive Profit Alert on Strong 2025 Growth and Naturade Acquisition
Jan 19, 2026
Beauty Farm Medical and Health Industry Inc. has issued a positive profit alert for 2025, forecasting revenue of at least RMB3.0 billion, up no less than 16% year on year, adjusted net profit of at least RMB380 million, up no less than 40%, and ne...
Beauty Farm Completes Acquisition of Shanghai Siyanli, Expands Network to 734 Stores
Jan 7, 2026
Beauty Farm Medical and Health Industry Inc. has completed the acquisition of 100% of Shanghai Siyanli Industrial, which becomes an indirect wholly owned subsidiary and will be fully consolidated into the group’s financial statements. Shangh...
Beauty Farm Commits RMB240 Million to Principal‑Guaranteed Wealth Products from SPD Bank
Dec 30, 2025
Beauty Farm Medical and Health Industry Inc. has disclosed that its subsidiaries Beijing Palaispa and Shanghai Beauty Farm Medical Healthcare have subscribed to a series of principal‑guaranteed wealth management products from SPD Bank, total...
Beauty Farm Medical & Health Industry Inc. EGM Resolution Passed
Dec 5, 2025
Beauty Farm Medical Health Industry Inc. announced that the resolution proposed at their Extraordinary General Meeting (EGM) held on December 5, 2025, was passed as an ordinary resolution. The resolution involved the approval of a Share Purchase ...
Beauty Farm Medical & Health Industry Inc. Boosts Shareholder Confidence with Share Purchases
Dec 3, 2025
Beauty Farm Medical and Health Industry Inc. announced an increase in shareholding by non-executive director Ms. Li Fangyu, who acquired an additional 52,000 shares, reflecting her confidence in the company’s future prospects. Additionally, ...
Beauty Farm Director Increases Shareholding, Signaling Confidence
Dec 2, 2025
Beauty Farm Medical Health Industry Inc. announced an increase in shareholding by non-executive director Ms. Li Fangyu, who acquired 21,000 ordinary shares, representing approximately 0.01% of the total issued shares. This acquisition reflects he...
Beauty Farm Enhances Market Confidence with Shareholder Moves
Dec 1, 2025
Beauty Farm Medical and Health Industry Inc. announced an increase in shareholding by a non-executive director, Ms. Li Fangyu, who acquired 41,500 shares, reflecting her confidence in the company’s future. Additionally, the company repurchas...
Beauty Farm Expands with Naturade Brand Acquisition
Dec 1, 2025
Beauty Farm Medical Health Industry Inc. announced a supplemental update regarding its acquisition of equity interest in businesses operating under the Naturade brand. The acquisition is expected to enhance operational control, strengthen brand p...
Beauty Farm Medical & Health Industry Inc. Announces Share Repurchase
Nov 28, 2025
Beauty Farm Medical Health Industry Inc. announced a voluntary on-market share repurchase, acquiring 80,000 shares at an average price of HK$25.09 per share, totaling approximately HK$2,007,420. The Board believes the repurchase reflects confiden...
Beauty Farm Medical & Health Industry Inc. Announces Share Repurchase
Nov 27, 2025
Beauty Farm Medical Health Industry Inc. announced a voluntary on-market share repurchase, buying back 100,000 shares for approximately HK$2,379,520. This move, part of a broader repurchase strategy, reflects the board’s confidence in the c...
Beauty Farm Expands with Naturade Brand Acquisition
Nov 18, 2025
Beauty Farm Medical Health Industry Inc. announced the acquisition of equity interests in subsidiaries operating under the Naturade brand, with a total consideration of RMB40.0 million. This acquisition will add 19 new direct stores to the compan...
Beauty Farm Medical & Health Industry Inc. Announces Acquisition Plans
Nov 16, 2025
Beauty Farm Medical Health Industry Inc. has announced an extraordinary general meeting to approve a share purchase agreement for acquiring 100% of Shanghai Siyanli Industrial Co., Ltd. The transaction involves issuing 15,798,147 shares at HK$28....
Beauty Farm Announces HK$1.2 Billion Shareholder Return Plan
Nov 4, 2025
Beauty Farm Medical Health Industry Inc. has announced a plan to enhance shareholder value by allocating up to HK$1.2 billion over the next three years for dividends and share repurchases. The company intends to fund these initiatives through int...
Beauty Farm Medical Announces Share Repurchase to Boost Shareholder Value
Oct 31, 2025
Beauty Farm Medical and Health Industry Inc. announced a voluntary on-market share repurchase of 40,000 shares, totaling approximately HK$1,236,230, as part of a broader repurchase strategy. The Board believes this move reflects confidence in the ...
Beauty Farm Announces Director’s Share Purchase and Share Repurchase
Oct 30, 2025
Beauty Farm Medical Health Industry, Inc. announced an increase in shareholding by a non-executive director, Ms. Yi Lin, who purchased 61,000 shares, reflecting her confidence in the company’s future. Additionally, the company conducted an ...
Beauty Farm Medical and Health Industry Inc. Announces Share Repurchase
Oct 28, 2025
Beauty Farm Medical and Health Industry Inc. announced a voluntary share repurchase, acquiring 30,000 shares on October 28, 2025, as part of a broader initiative that has seen the repurchase of 445,000 shares since October 15, 2025. The board beli...
Beauty Farm Medical and Health Industry Inc. Announces Strategic Share Repurchase
Oct 27, 2025
Beauty Farm Medical and Health Industry Inc. announced a voluntary repurchase of 40,000 shares on October 27, 2025, at an average price of HK$31.10 per share, totaling approximately HK$1,244,090. This move is part of a broader repurchase strategy ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.